The repair of DNA double-strand breaks occurs through non-homologous end joining or homologous recombination in vertebrate cells -a choice that is thought to be decided by a competition between DNA-dependent protein kinase (DNA-PK) and the Mre11/Rad50/Nbs1 (MRN) complex but is not well understood. Using ensemble biochemistry and single-molecule 5 approaches, here we show that the MRN complex is dependent on DNA-PK and phosphorylated CtIP to perform efficient processing and resection of DNA ends in physiological conditions, thus eliminating the competition model. Endonucleolytic removal of DNA-PK-bound DNA ends is also observed at double-strand break sites in human cells. The involvement of DNA-PK in MRN-mediated end processing promotes an efficient and sequential transition from non-10 homologous end joining to homologous recombination by facilitating DNA-PK removal.
Introduction
DNA-dependent Protein Kinase consists of a catalytic kinase subunit (DNA-PKcs) and the DNA end-binding heterodimer of Ku70 and Ku80 (Ku). Together, these proteins form an end recognition complex (DNA-PK) that binds to DNA double-strand breaks within seconds of break formation (1) . DNA-PK promotes the ligation of two DNA ends by ligase IV, aided by accessory 5 factors and in some cases accompanied by limited end processing (1, 2) . The recognition and repair of DNA breaks by the DNA-PK-associated non-homologous end-joining (NHEJ) machinery is generally considered to be the first and rapid phase of DNA repair, occurring within ~30 minutes of DNA damage, while homologous recombination is specific to the S and G 2 phases of the cell cycle and occurs over a longer time frame (3, 4) . DNA-PK is present at 10 micromolar concentrations in cells (5) and binds DNA ends in all cell cycle phases, even during S phase at single-ended breaks (6) .
The MRN complex regulates the initiation of DNA end processing prior to homologous recombination by catalyzing the initial 5ʹ strand processing at blocked DNA ends and by recruiting long-range nucleases Exo1 and Dna2 (4, 7) . At single-ended breaks during replication, 15 the nuclease activity of Mre11 was shown to be important for removal of Ku (6) , suggesting that MRN catalytic processing of ends during S phase is important for recombination-mediated repair of single-ended breaks. In addition, the presence of protein blocks on DNA ends has been shown to stimulate MRN(X) endonuclease activity in vitro (8) (9) (10) (11) (12) , consistent with the idea that chromatin-bound proteins stimulate MRN activities. Here we considered the possibility that the 20 presence of DNA-PK on DNA ends might regulate MRN-dependent end processing and that this interaction may be a critical component of the choice between NHEJ and homologous recombination pathways in human cells. 4 
Results
To test for the effect of DNA-PKcs on end processing by the MRN complex, we performed a nuclease assay with purified human MRN, CtIP, Ku, and DNA-PKcs (Fig. S1 ) on a 197 bp linear double-stranded DNA containing a single radiolabel at the end of one of the 5′ strands. Addition of all the protein complexes together to this substrate resulted in the appearance of a single major 5 cleavage product approximately 45nt in length (Fig. 1A, lane 2) . We previously reported MRNmediated removal of the Ku heterodimer alone, showing that MRN makes an endonucleolytic cleavage at approximately 30 bp from the DNA end (13) ; here we observe that the inclusion of DNA-PKcs in the reaction increases the efficiency of the cutting by approximately 50-fold as well as changing the position of the nuclease cleavage site to a location approximately 45 nt from 10 the end (Fig. 1A, lanes 2 and 3) . Importantly, efficient formation of the cleavage product requires CtIP, which is essential for DNA end resection in human cells (14) . Mre11 nuclease activity in vitro is strictly manganese-dependent (8, 15, 16) ; however, Mre11/Rad50 complexes from archaea and from T4 bacteriophage also exhibit nuclease activity in the absence of manganese when physiologically relevant protein cofactors are present (17, 18) . Here we observe that 15 human MRN makes endonucleolytic cuts in magnesium-only conditions and that this requires the presence of both Ku and DNA-PKcs (Fig. 1A, lane 10) . Since human cells do not contain high levels of manganese (19), we conclude that the physiologically relevant endonuclease activity of MRN is thus dependent on DNA-PK. Mre11 and CtIP both exhibit endonucleolytic activity (8, 20) so we asked which protein 20 is responsible for the catalysis. We found that substituting wild-type Mre11 with a nucleasedeficient form of Mre11, H129N (21, 22) , completely abolished DNA-PK-dependent cutting by MRN, whereas we observed robust activity with nuclease-deficient N289A/H290A CtIP (Fig. 5 1B, lanes 4 and 5); thus, we conclude that the processing is done by the catalytic activity of Mre11.
We previously observed that ATP binding by Rad50 promotes Nbs1-dependent endonucleolytic cutting by Mre11 (8, 15) . Exclusion of ATP or substitution of the nonhydrolyzable AMP-PNP analog for ATP blocks MRN nuclease activity in the presence of 5 DNA-PK ( Fig. 1B, lanes 6 and 7) , suggesting that ATP hydrolysis by Rad50 is critical for DNA-PK-promoted MRN nuclease activity. We also tested MRN complexes containing Rad50 K42A and D1231A proteins with mutations in the Walker A and Walker B ATP-binding motifs, respectively, that are deficient in ATP hydrolysis (23) . Both complexes failed to support MRN endonuclease activity (Fig. 1C ), confirming the requirement for Rad50 catalytic activity. 10
Phosphorylation of Ku has been shown to result in the removal of Ku from DNA (24), and autophosphorylation of DNA-PKcs also removes DNA-PKcs from the Ku-DNA complex (25) (26) (27) (28) (29) , therefore in reactions shown in Fig. 1A and B, we have also included an inhibitor of DNA-PKcs, NU7441, to block its kinase activity. Removal of the inhibitor reduced the efficiency of the reaction (Fig. 1B, lane 8 ), suggesting that reduced stability of DNA-PK on 15 DNA reduces the nuclease activity of MRN on the DNA-PK-bound substrate. However, the endonucleolytic product is still observed in the absence of the inhibitor (also see Fig. S2 ), thus blocking DNA-PKcs phosphorylation is not absolutely essential.
Small molecule inhibitors have been developed that specifically block either the exonuclease (PFM39) or the endonuclease (PFM01 and PFM03) activity of Mre11 (30) . We 20 found that PFM01 and PFM03 reduced MRN endonuclease activity by 60% and 98%, respectively, compared to 25% inhibition by PFM39 ( Fig. 1D ,E). Efficient inhibition by PFM03 6 and PFM01 are consistent with Mre11 endonucleolytic activity acting on DNA ends bound by DNA-PK in this assay. CtIP is phosphorylated by several different kinases in human cells (31)( Fig. 2A ). Some of these phosphorylation events have been shown to promote DNA end resection (8, 9, (32) (33) (34) (35) (36) (37) , most notably the CDK-dependent phosphorylation of T847. In addition, ATM/ATR 5 phosphorylation of T859 also plays an important role in CtIP binding to chromatin and CtIPmediated resection (38, 39) . To test the function of CtIP phosphorylation in the MRN endonuclease assay, we purified recombinant CtIP proteins containing phospho-blocking or phospho-mimic mutations at the T847 and T859 sites ( Fig. S1 ). Addition of these mutant proteins to the MRN endonuclease assay with DNA-PK shows that T847 and T859 10 phosphorylation are critical, as the phospho-deficient T847A and T859A mutants resulted in loss of CtIP stimulation (15-and 3-fold stimulation of MRN, respectively, compared to 43-fold by WT) (Fig. 2B , lanes 5-10, Fig. 2C ). We know that there is substantial constitutive phosphorylation of CtIP expressed and purified from insect cells (40) and infer from this result that T847/T859 phosphorylated species in the recombinant protein preparation are essential for 15 stimulation of the MRN endonuclease activity. In contrast to these sites, phosphorylation at S327 or the ATM sites S231, S664 and S745 appears not to be important for the endonucleolytic activity ( Fig. 2B , lanes 11-13). We previously reported that the ATM phosphorylation sites are important for CtIP intrinsic nuclease activity (40). Here we show that these sites do not regulate DNA-PK-dependent Mre11 endonuclease activity, consistent with our observation that the 20 N289A/H290A mutations that reduce CtIP nuclease activity also do not impact Mre11 function in this assay. 7 While mutation of the CtIP T847 residue to phospho-blocking alanine inhibited its stimulation of Mre11 nuclease activity, the phospho-mimic T847E mutant completely restored this ability in vitro (Fig. 2B, lane 6 ). This is important as the T847E allele of CtIP was previously shown to restore localization of CtIP to sites of DNA damage as well as the resection of doublestrand breaks, and promoted efficient CDK-dependent processing of these breaks (41) Exo1 is one of the critical long-range exonucleases that performs DNA end resection in 15 human cells (4) and we have previously shown a positive effect of MRN on Exo1-mediated degradation of DNA (13, 42, 43) . Despite the well-known importance of CtIP in resection in human cells, however, we have not observed any effects of recombinant CtIP on Exo1 activity in previous experiments. Here we examined the effect of CtIP on Exo1 on a plasmid DNA substrate in the presence of MRN and DNA-PK ( Fig. 2D ). As expected, Exo1 is substantially blocked by 20 the presence of DNA-PK in the reaction, an inhibition that is relieved by the inclusion of MRN and requires CtIP (Fig. 2D , lanes 4-6). This finding that CtIP stimulates the activity of Exo1 7-8 fold in the presence of DNA-PK is consistent with the effect of CtIP on Mre11 nuclease activity we observe on the labeled substrates ( Fig. 1 ).
We recently showed that MRN can remove DNA end blocks by sequential endo-exoendo activities, generating a double-strand break adjacent to the block (8, 13) , a model first suggested by processing of meiotic DNA breaks (44) . In the presence of DNA-PK bound to 5 DNA ends, we found that the MRN complex executes similar end-processing of the radiolabeled substrate to generate a new double-strand break. We detected a ~ 45 bp dsDNA product using native PAGE (Fig. 2E , lane 2), corresponding to the major product seen on denaturing gels ( Fig.   1 ). This activity was dependent on MRN and was enhanced when both Ku and DNA-PKcs were present in the reaction (Fig. 2E , lane 2). However, the formation of the dsDNA product was less 10 efficient (approximately 1 to 2% of the substrate cleaved at site proximal to the radiolabel) compared to the single-strand endonucleolytic product seen on denaturing gels (approximately 27 to 34% of the substrate cleaved adjacent to the labeled 5ʹ end)( Fig. 1A, B ).
The unexpected dependence of Mre11 endonuclease activity on DNA-PK suggests that there may be specific protein-protein interactions underlying the cooperative behavior. We tested 15 this by immobilizing purified, human CtIP on magnetic beads and monitoring binding of DNA-PK or MRN. Both MRN and DNA-PK bound to CtIP in an ATP-independent manner ( Fig. 2F ).
Binding analysis of Ku and DNA-PKcs separately showed that each of the components of DNA-PK has affinity for CtIP ( Fig. 2G ). Interestingly, binding of Nbs1 (added to this reaction separately from the MR complex) to CtIP is mostly independent of DNA-PK while binding of 20 MR to CtIP improves 7 to 8-fold with DNA-PK present. Addition of EtBr or Benzonase to the reaction did not affect the interaction, confirming that the binding is independent of DNA ( Fig.   S3A ). Although the stimulation of Mre11 nuclease activity requires CtIP phosphorylation on 9 T847 and T859, we did not observe any obvious deficiency in binding between CtIP, MRN, and DNA-PK with the T847A/T859A CtIP mutant protein ( Fig. S3B ), thus the effect of the phosphorylation does not appear to be manifested through CtIP association with the other factors.
5

Single-molecule observations show MRN/CtIP-mediated removal of DNA-PK and MRN from DNA ends
To examine the interactions between DNA-PK and the MRN complex in greater detail, we turned to single-molecule microscopy. In this "DNA curtains" assay, arrays of lambda DNA molecules (~48 kb long) are attached via a biotin-streptavidin linkage to a microfluidic flowcell 10 that is also passivated with a fluid lipid bilayer ( . This data suggests that co-localization of MRN with the DNA-PK complex is not sufficient to facilitate removal and that, consistent with our ensemble assays, phosphorylated CtIP is required for DNA-PK removal by MRN nuclease activity. It is notable that the rate of DNA-PK removal by MRN/CtIP under these conditions (t 1/2 = 324 ± 15 sec) is faster than the removal of Ku by DNA-PK-mediated phosphorylation (t 1/2 = 780 ± 30 sec), thus 5 the MRN-mediated pathway is likely to occur in a time-frame comparable to other pathways of Ku removal in cells.
Our previous studies showed that MRN could remove Ku from DNA ends via a manganese-dependent reaction (8, 13) . Here we observe approximately the same kinetics of DNA-PK release catalyzed by MRN and CtIP as we did previously for Ku, but in magnesium-10 only conditions (all of the single-molecule experiments shown here were performed in the absence of manganese). These results demonstrate that DNA-PK stimulates Mre11 nuclease activity in the absence of manganese in physiologically relevant conditions and that CtIP is an essential component of this reaction.
These observations suggest a conserved mechanism for removal of blocks from DNA 15 ends by the MRN complex (model in Fig. 4E ). At two-ended double-strand breaks, NHEJ would first engage the ends, and in cases where the ends are compatible, the ends would undergo productive end-joining. In situations where NHEJ fails and the DNA-PK complex remains at the DSB ends, Ku could be removed by DNA-PK-mediated phosphorylation (24). Alternatively, MRN can remove the complex through endonucleolytic processing, a reaction which is greatly 20 enhanced by phosphorylated CtIP and is dependent on DNA-PK, as we show in this study. MRN activity nicks either one or both the strands close to the DNA-PK complex in a sequential or simultaneous manner. The nicked or freed end is then used for extensive 5' to 3' resection by 12 exonucleases allowing damage repair through homologous recombination or homologydependent mechanisms.
MRN nuclease-mediated cutting of DNA-PK-bound ends occurs in human cells
To determine if nucleolytic removal of DNA-PK occurs in human cells, we performed a chromatin immunoprecipitation (ChIP) assay using the inducible AsiSI restriction enzyme 5 system in U2OS osteosarcoma cells (47). We modified the standard ChIP protocol (Fig. S4 ) by reducing the duration of formaldehyde crosslinking and eliminating the extensive sonication used to fragment DNA. This gentle lysis procedure, which we are naming "Gentle Lysis And Size Selection-ChIP", or GLASS-ChIP, allowed us to specifically separate small (50 to 300 bp) DNA-PK-associated DNA fragments from the bulk chromatin. The fragments were then further 10 purified and used for quantitative PCR analysis. We monitored four genomic AsiSI sites (48) and found that this procedure generated DNA-PK-associated DNA fragments at all four sites that were strongly dependent on 4-OHT addition (Fig. 5A ).
When cells were exposed to DNA-PKcs inhibitor NU7441 during AsiSI induction, quantitation of DNA located very close (~30 nt) to the AsiSI genomic sites showed a 25-250-15 fold increase over background levels (i.e. levels of product formed with NU7441 but in the absence of 4-OHT induction)( Fig. 5A) , consistent with the nucleolytic removal of DNA-PKbound DNA ends we observed in vitro. These levels dropped significantly when measuring sites located farther away (~300 nt) from the AsiSI cut site (Fig. S5 ), and no signals above background were observed at representative locations distant from AsiSI sites. With DNA-PKcs 20 inhibitor present as it is here, we expect that NHEJ is blocked and MRN cleavage of DNA-PKbound ends is maximal, as we observed in purified protein reactions ( Fig. 1 and 2 ). 13 Induction of AsiSI with 4-OHT in the absence of DNA-PKcs inhibitor also generated DNA in the GLASS-ChIP assay, approximately 3 to 160-fold higher than background depending on the site, measured with primers 30 nt from the AsiSI location ( Fig. 5A inset) . Under these conditions NHEJ is not blocked, thus the release of DNA-PKcs with associated DNA is expected to occur only as a consequence of DSB processing. Importantly, the observation of these 5 products in the absence of DNA-PKcs inhibitor shows that processing of DNA-PKcs-bound ends occurs in human cells under normal physiological conditions.
To determine if the DNA-PK-bound products arise through Mre11 nuclease activity we treated the cells with endonuclease inhibitor PFM03 based on our in vitro observations ( Fig. 1D -E). In preliminary experiments, we found that addition of 4-OHT to induce AsiSI activity in cells 10 also exposed to PFM03 (100 µM) and DNA-PKcs inhibitor NU7441 resulted in complete cell death within 1.5 h. To circumvent this, we limited the treatment with 4-OHT and both DNA-PKcs and Mre11 inhibitors to 1 hour. In the absence of the Mre11 inhibitor, we observed short DNA fragments at 3 of 4 of the genomic loci tested that were dependent on 4-OHT ( Fig. 5B ), albeit at 10-to 20-fold reduced levels compared to the 4 hour 4-OHT induction (Fig. 5A ). With 15 the addition of PFM03, there was a significant reduction in the recovery of these fragments, indicating that Mre11 nuclease activity is indeed responsible for the creation of DNA-PK-bound DSB products (Fig. 5B ).
Discussion 20
Here we have shown that DNA-PK plays an important role in DNA end processing through its stimulation of Mre11 endonuclease activity. The extremely high concentration of DNA-PK in mammalian cells, particularly in human cells (5) , and the high affinity of Ku for DNA ends (49) 14 means that double-strand break ends will be immediately bound by DNA-PK (see model in Fig.   4E ). Removal of this block can be promoted by several distinct mechanisms: by DNA-PKcs phosphorylation of Ku70 which reduces its DNA-binding affinity (24), by ubiquitination of Ku and degradation by proteasome-dependent or independent mechanisms (50-52), or single-strand or double-strand endonucleolytic incision of DNA by MRN as we show in this study. Single-5 strand DNA cutting by Mre11 followed by 3′ to 5′ Mre11 exonuclease activity was demonstrated as a mechanism for Spo11 removal by Mre11-Rad50-Xrs2 (MRX) in yeast (44) .
We also demonstrate in this work that double-strand DNA cutting by MRN is promoted Nbs1, CtIP wild-type, and CtIP mutants) were expressed and purified from Sf21 insect cells as described previously (8, 23, 40) . 3XFLAG-MRN, 3XHA-Ku70/80 heterodimer, and Exo1-biotin 20 were made as described previously (13) . DNA-PKcs from human cells was purified as described previously (57). The Ku70(5A) mutant (T305A/S306A/T307A/S314A/T316A) was made from the baculovirus transfer vector containing wild-type Ku70 by QuikChange mutagenesis 16 (Stratagene) to create the 5A mutant expression plasmid pTP4143 and the corresponding bacmid pTP4177, which was used with wild-type Ku80 baculovirus to infect Sf21 cells and purify Ku(5A). with pTP3718 followed by purification on a native 0.7% agarose gel as described previously (8) .
The DNA substrate used in Figure 2A was made by digesting pCDF-1b plasmid with SspI to create a 3.6 kb linear DNA with blunt ends, and was used without further purification. The lambda DNA substrate used in single molecule studies was prepared as described previously (13) . Proteinase K was added and incubated at 37°C for 90 min followed by 10 min incubation at 15 50°C. These reactions were separated in a 0.7% native agarose gel in 1X TBE buffer, stained with SYBR green and visualized with a Chemidoc Gel Imager (Bio-Rad).
Protein-protein interactions
Immunoprecipitation assays were performed with anti-CtIP antibody (Active Motif 14E1) in mM DTT, 1 mM ATP, 0.2 mM NU7441, 5 mM MgCl 2 and 0.2 mg/ml BSA at 37°C for 10 min. 18 The reaction was then incubated with 2 µg anti-CtIP antibody, 0. 
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